Aperio Group’s Esperion Therapeutics ESPR Stock Holding History

Aperio Group’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-614	Closed	-$29K	–	2455
2019 Q2	$29K	Buy	+614	New	+$28.8K	﹤0.01%	2629
2018 Q2	–	Sell	-5,995	Closed	-$434K	–	2269
2018 Q1	$434K	Buy	5,995 +597	+11%	+$43.8K	﹤0.01%	1763
2017 Q4	$355K	Hold	5,398	–	–	﹤0.01%	1864
2017 Q3	$271K	Buy	5,398 +8	+0.1%	+$386	﹤0.01%	1971
2017 Q2	$249K	Buy	+5,390	New	+$198K	﹤0.01%	1994

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return